Read articles from Oceania

October 14, 2026 by clearingtheair.eu

Anti-nicotine campaigns rarely present themselves as propaganda; they present themselves as protection. That is why scrutiny matters. Funding networks, advocacy strategies and institutional alliances can shape which evidence is amplified, which voices are excluded and how safer nicotine products are framed to the public. A serious public health debate should be able to follow the influence behind the message, especially when the result may be fewer options for adults trying to leave cigarettes behind.

October 12, 2026 by substack.com

A snapshot can show where nicotine use is at one moment, but it cannot explain the whole journey. Smoking, vaping and switching are dynamic behaviours, shaped by timing, motivation, access and whether people move fully away from cigarettes. Treating one data point as a final verdict risks missing the direction of change that matters most for harm reduction. Better analysis follows the pathway, not just the photograph.

October 12, 2026 by gfn.tv

New Zealand’s progress shows what tobacco policy can look like when harm reduction is treated as part of the solution. Smoking has fallen alongside access to vaping, suggesting that lower-risk alternatives can help accelerate the move away from combustion when smokers are given practical options. The lesson is not that regulation should disappear, but that it should support the direction of change already reducing harm. Public health should learn from countries where smoking is falling fastest, not dismiss the tools helping make it happen.

October 09, 2026 by pearlsandirritations.com

Australia’s nicotine policy is drifting further from the reality consumers are living in. Cigarettes remain legal, illicit tobacco is expanding, and many vapers are navigating workarounds, informal supply or rules that do not match how people actually quit smoking. That gap matters because policy cannot reduce harm effectively while pretending demand has disappeared or that restriction equals control. A better approach would start from real behaviour: keep people inside legal channels, make safer alternatives accessible, and measure success by fewer people smoking.

October 08, 2026 by github.io

The EU’s direction on nicotine bans should be judged by what it leaves behind. Removing smoke-free alternatives from legal markets does not remove nicotine use; it can leave adult smokers with fewer routes away from cigarettes and give illicit suppliers more room to grow. That is the risk of policy built around exclusion rather than comparison. A European tobacco strategy should distinguish between products, protect young people through enforcement, and keep lower-risk options available for those still exposed to combustion.

October 07, 2026 by clearingtheair.eu

One hundred and twenty thousand lived experiences should be difficult for policymakers to ignore. Behind the EU nicotine consultation are smokers, vapers, pouch users and people who have already changed their risk by moving away from cigarettes. Their evidence is not laboratory data, but it is evidence of how policy works in real life. Europe’s next nicotine framework should listen to those experiences before deciding which products adults are allowed to understand, access or use.

October 05, 2026 by junonews.com

Ian Irvine argues that Canada’s restrictions on nicotine pouches undermine smoking cessation by making lower-risk alternatives harder to buy than cigarettes. He criticizes the Ontario Tobacco Research Unit’s opposition to nicotine substitution, advocating harm reduction rather than eliminating all nicotine use. Citing vaping initiatives in New Zealand and the UK, alongside declining smoking rates in Sweden and Norway, he urges Ottawa to improve access to pouches, vapes and heated tobacco products. Although nicotine causes dependence, Irvine maintains that these alternatives pose substantially lower health risks than smoking. The article discloses that some of his research received tobacco-policy foundation funding and that nicotine producers covered conference expenses.

October 02, 2026 by protectingtaxpayers.org

The text argues that growing evidence supports tobacco harm reduction products, especially e-cigarettes, as alternatives for adult smokers. It cites a Cochrane review of nine trials finding vaping more effective than traditional nicotine replacement therapies for quitting, with no serious harms identified in those trials. It also describes FDA authorization of reduced-risk marketing claims for ZYN nicotine pouches. The author contends that restrictive policies discourage cessation and fuel illicit markets, while cigarette smoking causes substantial mortality and economic costs. The text urges clinicians and policymakers to prioritize scientific evidence over stigma and prohibition, arguing that access to lower-risk nicotine products could improve public health.

September 25, 2026 by substack.com

Australia’s nicotine debate often talks about systems, markets and enforcement, but the people most affected can disappear from view. Smokers who cannot quit, vapers pushed into prescription workarounds, and consumers navigating illicit supply are not footnotes to policy — they are the evidence of how policy works in practice. A strategy that ignores them may look tidy from above while failing on the ground. Public health should count lived experience as part of the evidence, not as an inconvenience to the model.

September 22, 2026 by substack.com

A smoking rate is only as reliable as the data behind it. Australia’s 5.8% figure raises questions about what is being counted, what may be missed and how illicit tobacco use affects the picture. A low number can shape policy confidence, media narratives and international reputation, so the methods matter. Before Australia is held up as a success story, its smoking data needs to match the reality of the market.